Can omeprazole reduce the risk of esophageal adenocarcinoma in patients with Barrett’s esophagus and how effective is it in preventing progression?
Lakshya KumarExplorer
Can omeprazole reduce risk for esophageal adenocarcinoma in Barrett’s esophagus?
Share
Omeprazole can reduce esophageal acid exposure and control reflux symptoms, potentially lowering the risk of progression from Barrett’s esophagus to esophageal adenocarcinoma. However, its effectiveness in preventing cancer is not conclusively proven and further studies are needed to confirm any protective effect.